Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No. penny traders are, Koos is making progress
No, not the content
The context
Might be difficult for you to understand, best to move on
No one would pay $100,000 for a e-junk mail ad. It's all bs
Egg zakley
Looks like just a copy of the website
it's bs, just some guy in his basement
Nice
New n improved FDA
Submission
This is about to rise from the ashes
holding
Most are holding
But but you have another chance at a r/s in the spring
See today's pr
With upcoming PRs, new investors will be going to the site.
Reason for everything...
and the real news hasn't hit yet
Hint hint
Old post that was retweeted
This is about to climb
unless you can't see your own shadow, you might want to start loading, the waves are building for nice rides.
fair warning given, I'm running silent, running deep from now on
not legally
I've heard a bit more...
next we'll see E Lilly jumping in to move on this
Like I said, just around he corner
Please be seated and fasten your seat belts
I smell news around the bend
10 Q out
C Ichim just updated LinkedIn profile, still showing working here
New tweet from rgbp
Congrats on hitting over 10,000 posts, I guess
Any upcoming funding by E Lily PR will state that RGBP is a subsidiary of BMSN
No worries
Glad u agree
Expect a PR related to E Lilly funding studies based on RGBP review and finding E Lilly owned study material.
Like the open and frequent communication, vastly different from 2 yrs ago.
Going to be a nice summer
Maybe .....Eli? Down the road
Mexico results coming, obvious ELilly already knows
Happy July
Indeed
prime candidate for ignore
Pacific time
everyone needs an agent
actors
athletes
job recruits (recruiters)
biotechs
it's business
PR on status of tests coming
News will continue
Buy and hold in your back pocket